Bl 29 - analogs
| Prices in pharmacies: Instructions Bl 29 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Nicergoline ✘ (incl) Tamsulosin ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 48% Gb 25 neutral
- 41% Bl 22 neutral
- 39% Bl 39 neutral
- 37% Bl 25 neutral
- 36% Bl 27 neutral
- 34% Bl 28 neutral
- 33% Du 6 neutral
- 32% Sp 8 neutral
- 30% Gb 27 neutral
- 30% Du 5 neutral
- 29% Gb 28 neutral
- 28% Du 1 neutral
- 27% Bl 56 neutral
- 27% St 25 neutral
- 26% Kid 14 neutral
- 25% Du 4 neutral
- 25% Ren 9 neutral
- 25% Kid 21 neutral
- 24% Ren 5 neutral
- 24% Bl 54 neutral
- 24% Du 2 neutral
- 24% Ren 11 neutral
- 24% Дань-нан-дянь neutral
- 23% St 3 neutral
- 23% Gb 38 neutral
- 23% Bl 48 neutral
- 21% Bl 57 neutral
- 21% Ren 8 neutral
- 21% Kid 20 neutral
- 20% Sp 2 neutral
- 20% Bl 45 neutral
- 20% Bl 26 neutral
- 20% Bl 49 neutral
- 19% Du 7 neutral
- 19% Ren 13 neutral
- 19% PC70 Чжу-чжан neutral
- 18% St 22 neutral
- 18% Kid 7 neutral
- 18% PC66 Пи-гэнь neutral
- 18% Du 12 neutral
- 18% Ren 3 neutral
- 18% Ren 14 neutral
- 17% Si 3 neutral
- 17% Sp 17 neutral
- 17% Bl 52 neutral
- 17% Bl 38 neutral
- 17% Kid 8 neutral
- 17% Bl 46 neutral
- 16% Sp 9 neutral
- 16% Bl 40 neutral
Learn more about the selection of analogues
- The drug has «Bl 29» no complete analogues; 51 analog by action, the most similar - Gb 25 .
- Medical online service has selected the best substitutes for Bl 29 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Bl 29 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.